MedX Health Corp.'s RJ-Laser Veterinary Products Selected by Vet Novations
Canada
Details and updates on new partnerships at AGM
Now scheduled for November 17th, 2010
Mississauga, ON, Sept. 30 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief today announced that its exclusive line of RJ-Laser "Veterinary" products has been selected by Vet Novations Canada, as the exclusive therapeutic laser line of products for their customers. Vet Novations will be the exclusive provider of the MedX Health RJ-Laser Veterinary line to the more than 8,000 veterinarians in Canada.
"Vet Novations is the right partner for us as we enter this important new market, because they have earned the respect of veterinarians by demonstrating their expertise in a wide variety of technologically advanced medical diagnostic equipment, coupled with a outstanding commitment to education and customer service," said Steve Guillen, President & CEO of MedX.
"This is an exciting step forward for MedX Health in opening a market with the expectation of tremendous growth and potential that we have all envisioned and strategized", said Louie Canitano, Executive Vice President of Operations at MedX.
Clinical research and evidence show that animals will obtain the same benefits as humans from the positive effects of photo bio-stimulation used for a variety of musculoskeletal conditions and wounds.
Additional information and updates on other recently announced partnerships will be covered at the Annual General Meeting of Shareholders, scheduled for Wednesday, November 17th, at 4 p.m. at the National Club, 303 Bay Street, Toronto, Ontario, Canada.
About Vet Novations Canada
Vet Novations Canada is the Canadian partner of Scil Animal Care Company, Abaxis, Dr. Fritz, Aesculap, Sykon, O&R Technology, Konica Minolta and ITC who are the international leaders in veterinary diagnostics. Vet Novations' goal is to provide the veterinary community with technologically advanced products that adapt easily to a variety of practice styles and situations. Vet Novations specializes in the following veterinary diagnostic equipment: Hematology Analyzers, Diagnostic Chemistry Analyzers, Surgical Lasers, Ultrasound, Computer Radiography (CR) and Digital Radiography (DR). Vet Novations realizes that ease of use, reliability, and low operating costs are of great importance to veterinarians. They are focused on delivering these qualities with every product line.
Vet Novations Canada Inc. is located in Barrie, Ontario, Canada, and has been serving veterinarians across Canada since January 2003. In that short time their competent team and state-of-the-art product portfolio have attained a high acceptance in the veterinary world as a partner for in-house-lab solutions. Vet Novations has a national sales force that can serve customers across Canada. One of Vet Novations core strengths is their unparalleled customer support; providing support to customers 6 days a week for any question they may have - free of charge!
About MedX Health Corp.
MedX is a leading North American developer and manufacturer of low level laser and light medical devices for the drug free and non-invasive treatment of tissue damage and pain in numerous medical settings including dental, rehabilitation and wound care. MedX is the world's only company focusing on developing and delivering a broad cross-section of technologies and products involved in healing using light therapy. MedX is committed to advocating for, the bringing of non-invasive, drug-free healing nature of light to people seeking relief from pain and other physical ailments.
MedX's strategy is to build upon its success in bringing relief of conditions in a non-pharmacologic manner in the rehabilitation market through key partnerships, acquisitions, strong patent protection as well as developing and commercializing advanced products in the dental and wound-care markets that will position the company to increase revenue. In addition, MedX plans to accelerate the development of a new product aimed at the rapidly-growing wound care market: its "Photobandage™", a bandage technology that allows a wound to be bathed in light, designed to enhance the healing process. The Company intends to license this new technology to one or more major wound care companies for further development of marketing and sales.
Brand products are US FDA approved, Health Canada cleared, and CE Marked and are produced in an ISO 9001 and 13485 certified manufacturing and testing facility. For a complete profile of MedX Health Corp. and its products visit www.medXhealth.com
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information may include statements regarding the Company's future plans, objectives, performance, growth, profits, operating expenses or its underlying assumptions. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedX to be materially different from those expressed or implied by such forward-looking information, including uncertainty of successful development of new products, uncertainty of successful manufacturing or marketing of products, uncertainty of commercial acceptance of products, uncertainty concerning governmental regulation, dependency on key employees and relationships, rapid technological changes, foreign currency fluctuations. MedX does not undertake to update any forward-looking information, except in accordance with applicable securities laws
For further information:
Contacts:
Investors:
Steve Guillen
President and Chief Executive Officer
MedX Health Corp.
Phone: (905) 670-4428
[email protected]
Share this article